Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€40.80
02.02.24
-
-
03.02.24

Could be worthwhile Investment >10% per year
blaugold 
02.02.24 50%
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€47.60
05.01.24
-
05.01.25
0.63%
05.03.24

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
fenjal 
05.01.24 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€75.96
02.01.24
€80.00
02.02.24
-6.29%
22.01.24

Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
RudolfL 
02.01.24 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€529.00
18.12.23
€558.00
18.12.24
6.62%
06.01.24

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
18.12.23 50%
sell
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€526.00
14.12.23
€558.00
14.12.24
0.57%
18.12.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
14.12.23 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€75.86
04.11.23
€89.00
04.12.23
-4.82%
05.12.23

Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
RudolfL 
04.11.23 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€568.50
11.10.23
€558.00
11.10.24
-7.48%
14.12.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
11.10.23 50%
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€246.80
19.09.23
€250.00
19.09.24
4.13%
27.09.23

Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
Traumtanz 
19.09.23 50%
sell
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€533.50
19.09.23
€558.00
19.09.24
6.56%
11.10.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
19.09.23 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€555.50
15.09.23
€558.00
15.09.24
-3.96%
19.09.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
15.09.23 50%
buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€96.82
18.08.23
-
18.08.24
7.52%
15.02.24

Dirk1 
18.08.23 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€502.50
17.08.23
€510.00
17.08.24
10.75%
13.09.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
17.08.23 50%
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€152.60
24.07.23
€155.00
24.07.24
3.47%
16.08.23

High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Traumtanz 
24.07.23 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€422.40
27.06.23
€800.00
31.01.29
20.50%
01.10.23

Could be very worthwhile Investment >20% year
BiotechBee 
27.06.23 80%
buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€289.75
29.05.23
-
29.05.24
22.71%
15.02.24

Dirk1 
29.05.23 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€35.70
22.05.23
€50.00
22.05.24
1.68%
08.06.23

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Traumtanz 
22.05.23 70%
sell
Pfizer Inc.

Start price
Target price
Perf. (%)
€33.95
22.05.23
€50.00
31.07.23
5.15%
22.05.23

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Traumtanz 
22.05.23 70%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€388.00
06.05.23
-
06.05.24
83.76%
07.05.24

StockNews.com 
06.05.23 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€388.00
05.05.23
€395.00
05.05.24
3.52%
12.05.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
05.05.23 50%
buy
Biogen Inc.

Start price
Target price
Perf. (%)
€281.00
01.05.23
€317.14
01.05.24
-28.01%
02.05.24

Guggenheim 
01.05.23 50%
buy
Align Technology

Start price
Target price
Perf. (%)
€290.05
29.04.23
-
29.04.24
-3.29%
30.04.24

StockNews.com 
29.04.23 50%
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€216.80
29.04.23
-
29.04.24
19.93%
30.04.24

StockNews.com 
29.04.23 50%
buy
Illumina Inc.

Start price
Target price
Perf. (%)
€199.00
25.04.23
€307.07
25.04.24
-43.41%
26.04.24

Royal Bank of Canada 
25.04.23 50%
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€222.60
24.04.23
€263.03
24.04.24
15.03%
25.04.24

Oppenheimer Holdings Inc. 
24.04.23 50%
buy
Medtronic plc

Start price
Target price
Perf. (%)
€79.62
24.04.23
-
24.04.24
-6.05%
25.04.24

Barclays PLC 
24.04.23 50%